Discovery & Development Europe 2026

Estrel Congress Centre, Berlin, Germany

Discovery & Development Europe 2025
The European Edition Has Now Concluded
But The Journey Continues
Next Stop: San Diego, CA | October 02 - 03, 2025
Hear From 2025's Event Moderator
Mirko Bischofberger Founder, Science Studios
After welcoming attendees and kicking off the event, Mirko Bischofberger joined us for an interview to talk about what’s happening in the discovery and development industry—offering his take on what's shaping the future.
Gala Dinner: A Night of Celebration
An evening of connection, recognition, and great conversation.
Our Frontiers of Success Gala Dinner brought together attendees for a relaxed evening of networking and celebration. Guests enjoyed a three-course meal and opening remarks from Philippe Marc of Novartis, honouring the achievements driving progress in drug discovery and development.

Advancing Therapeutic Innovation Through Multi-Omics Research
NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics.
There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology.
Hear from past attendees of last year's Biologics 2024 conference
Explore the NextGen Omics & Spatial Biology US 2025 Programme

NextGen Biomed 2025 is supported by our
Scientific Programme Partner The Antibody Society
Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration in Drug Discovery, Formulation and Delivery including:
Drug Discovery & Automation Programme - Key Themes
Panel Discussion: Technological Advancements For Novel Target Discovery
- Application of new technologies in identifying therapeutics for novel or currently undruggable targets
- Utilising AI/ML
- Challenges & future opportunities
Panellists include Giovanni Spagnolli, Chief Technology Officer, Sibylla Biotech, Ian Roberts, Senior Director, Digital Biology, Healx & Zoran Rankovic, Director, Center for Protein Degradation, The Institute of Cancer Research
Panel Discussion: Novel Platforms & Techniques To Improve Hit Identification
• Optimising Hit discovery
• Minimising false positives
• Integration of techniques
Moderated by Jonathan Hopper, Vice President Platforms & Founder, OMass Therapeutics
Panel Discussion: Fostering Partnerships & Collaboration In 2025 – as part of our newly introduced Early-Stage R&D Innovation Programme
- Emerging technologies & techniques
- Cross-sector partnership
- Open innovation
Moderated by Alexander Natz, Secretary General, EUCOPE & panellists from Cicio Holdings, BioAge Labs, European Commission, Pfizer & Business Region Gothenburg
Panel Discussion: Breakthrough Biotech: How Research Leaders Fund The Next Big Idea
- How research leaders identify and support fundable biotech innovations
- Overcoming early-stage funding gaps in biotech startups
- The role of research partnerships with pharma, VCs, and industry in startup success
- What startups can learn from research-backed biotech wins
Panellists include Christoph Rösli, Director of Research Bern, CSL Behring & Member of the Selection Board, BaseLaunch; David Jenkinson, Head of Childhood Cancer Translational Challenge, LifeArc; David Dexter, Director of Research, Parkinsons UK
Fireside Chat: Impact of AI & Big Data in Drug Discovery & Development
Panel Discussion: Translational Studies to Support Better Drug Design
- Bridging the gap between pre-clinical & clinical research
- Biomarkers & AI/ML in translational research
Moderated by Philippe Marc, Executive Director, Global Head of Integrated Data Sciences, Novartis
Panel Discussion: Fostering Collaboration To Accelerate Neurodegenerative Disease Research
• Pharma, biotech & academic partnerships
• The need for innovation, data & technology in CNS research
• Challenges to be solved through collaboration
Moderated by Emma Mead, Chief Scientific Officer, Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford. Panellists include Knut Biber, Research Fellow & Head of Glial Biology Team, AbbVie; Sarah Jolly, Principal Scientist, LifeArc; Michael Johnson, Professor of Neurology & Genomic Medicine, Imperial College London
Day 2 Breakfast Workshop - LifeArc: Biomarkers In Neurodegenerative Diseases: From Detection To Progression - Are Blood -Based Biomarkers Enough?
- Beyond blood-based biomarkers?
- Are we any closer to a solution?
- Application of AI/ML
Panel Discussion:
Automation & Robotics In Drug Discovery & Development – Where Are We Now?
• Impact of automation
• AI/ML
• Robotics in lab processes
Moderated by Rekha Lakshmanan, Global Head of Data Office, AstraZeneca
Panellists include: James Love, Vice President Cross Modalities Workflows, Novo Nordisk, Sarah Trice, COO & Head of US Operations, XtalPi & Tom Kissling, pRED Lab Automation Partner, Roche
Day 2 Breakfast Workshop: SiLA & AnIML Splash
• Splash! Is a unique event for every digital lab enthusiast. It combines an educational part with a hands-on session to try out standards in action. Pick up the details on the popular SiLA and AnIML standards, understand how they work and where you can put them to use. Our hands-on session lets you experience the standards in action firsthand. We’re bringing real and cloud-based instruments and lots of example data sets
• Feel free to bring an instrument or your own data
Formulation and Delivery Programme - Key Themes
Panel Discussion: Moving Beyond Oral Delivery
• Nanoparticles
• Inhalation
• Transdermal
• Developments with Oral Delivery
Moderated by Sandor Batkai, Life Science Consultant, Former, Head of Medical Research and Intelligence, Cardior Pharmaceuticals
Panellists include:
• Moein Moghimi, Professor of Nanomedicine & Pharmaceutics, School of Pharmacy at Newcastle University
• Kamalinder Singh, Professor of Pharmaceutical, Technology & Drug Delivery
• Karsten Mäder, Professor, Martin Luter University Halle-Wittenberg
Panel Discussion: Developing New Biotherapeutic Modalities While Ensuring Robustness And Quality In Their Formulations
- Improve the stability profile of biomolecules
- New excipients
- Impact on product quality and stability
- Alternative ways of formulation
Moderated by Amardeep Bhalla, Executive Director, Regeneron
Panellists Include:
• Ramesh Kashi, Former Senior Scientific Director, Bristol-Myers Squibb
• Tanvir Tabish, Director, Early Formulation Development, AstraZeneca
• Jack Palmer, Field Application Scientist, Advanced Instruments
• Martinus Capelle, Scientific Director, Head of Process & Delivery, Johnson & Johnson Innovative Medicine
Roundtable: Discovery And Delivery Of Therapeutics Across The Blood Brain Barrier – Where Are We Now?
- Challenges of drug delivery across the BBB
- Advances in nucleic acid brain therapies
- Future technologies and translational strategies
Moderated by Shadi Farhangrazi, Chief Executive Officer, S.M. Discovery Group and Moein Moghimi, Professor of Nanomedicine & Pharmaceutics, School of Pharmacy at Newcastle University
Meet Our Expert Speakers
The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Discovery & Development Europe 2025: 23 - 24 June 2025, Basel, Switzerland






















Schedl_quantro-tx.jpg?length=600&name=1a7420d5-7d72-4600-b14a-ead67fd7791c-2-11764368speaker_photo-039_20220601_(c)Schedl_quantro-tx.jpg)







.jpg?length=600&name=e73c85c3-43f1-4040-a19a-58133b2c8d0e-2-11764368speaker_photo-KITZ_vanTILBURG-Cornelis_180502_2988-(6).jpg)









































.jpg?length=600&name=1331ca3f-d428-4603-8c2e-f580543806cd-2-11764368speaker_photo-E4E7916C-3A57-465C-93C7-31BC36FB8F34-(1).jpg)

.jpg?length=600&name=bf0f9a64-4ef1-48c0-a59b-cf12aabf7598-2-11764368speaker_photo-20250203_102420-(1).jpg)


















.jpg?length=600&name=5d9d5049-7369-4b94-97b4-06cd49798ce9-2-11764368speaker_photo-Sagar-pic-Image-(2).jpg)


















-For-Web_00014-(1).jpeg?length=600&name=87a22798-6486-4caf-9641-7591cee861af-2-11764368speaker_photo-2025_01_06_KQ_Labs_JPEG-8-bit-300ppi-(sRGB)-For-Web_00014-(1).jpeg)











Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.
Interested in Sponsoring NextGen Biomed?
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
Meet Our Esteemed Sponsors
Platinum Sponsors


Gold Sponsors






Silver Sponsors













.jpg?length=600&name=a396bca6-7435-42de-8524-0ee4844b758e-2-5668375logo-standardbio-color-logo-blue-outline-blue-TM-(2).jpg)
Bronze Sponsors





.png?length=600&name=23c79081-69ce-4042-a188-0a0e10023652-2-5668375logo-Hawk-(RGB-Full-Colour).png)



.png?length=600&name=3ebab810-7368-4d37-bc16-77d994699581-2-5668375logo-RareCyte_Logo_PMS7585-CoolGray11-(R).png)
.png?length=600&name=Zifo_Master%20Logo_Two%20colour_RGB%20(002).png)
Network & Programme Sponsors

.png?length=600&name=77f962ea-48c4-4469-ac13-19f7332176c0-2-5668375logo-DLS-Logo-FullColor-noTag-(4).png)
.png?length=600&name=708bd68b-02d3-4436-8882-e6181f86f6da-2-5668375logo-Horizontal-Logo-(White-Background).png)


.png?length=600&name=ccf7bc56-af8b-49fe-b50e-b8bdf467ba91-2-5668375logo-StellaromicsLogo-(7).png)



Start-Ups
Who Sponsored Discovery & Development Europe 2025?
Platinum Sponsors



Gold Sponsors





.png?length=600&name=0bfa374f-caeb-4bd5-9f24-9b176c56bb3b-2-5668375logo-Pharmaron-Logo-High-Resolution-(4).png)


Silver Sponsors










Your partner of choice in bringing therapeutics to life
Nuvisan is a full-service contract research organisation (CRO) and development and manufacturing organisation (CDMO) with state-of-the-art laboratories in Germany and France.
Our pharmaceutical, biotechnology, venture capital and non-profit clients partner with us because our high-quality end-to-end solutions and scientific expertise enable us to streamline and accelerate drug discovery and development – from ensuring target understanding to helping bring therapeutics to life.
Founded over 40 years ago by a team of pharma industry innovators, Nuvisan has established a reputation for expertise and professionalism. Our team leaders have extensive experience in the biopharma industry, and our unique centres of excellence – for drug discovery in Berlin, formulation and GMP manufacturing in Sophia Antipolis, and our bioanalysis hub in Neu-Ulm – enable our experienced scientists to help guide and advance projects. We know how to discover, develop and bring the next generation of medicines to market. At the same time, we are committed to flexibility, transparency and collaboration in our approach, working closely with you to adapt to your individual needs, minimise risks and help deliver your project.








Bronze Sponsors



.jpg?length=600&name=61ac7f24-46f1-4373-9564-8293c215c0a7-2-5668375logo-CDDV_L_BLUE_ON_WHITE_CMYK-(9).jpg)





Network & Programme Sponsors







.jpg?length=600&name=c8f3ee46-970d-4da4-984f-fe6394fe9ac0-2-5668375logo-Glatt_PS_Mailchimp-header_schmaler-(1).jpg)





.png?length=600&name=86519b3d-ae0b-4b81-8d80-029ef5c96390-2-5668375logo-Nuclera_Logo_Principal_Blue-(3).png)





Start-Ups








The NextGen Biomed Young Scientist Awards include the best poster presentation award and are intended to honour an outstanding individual performance for a scientific work by a PhD student, PostDoc or early career scientist.
Please submit your poster presentation by no later than 13th January 2025 in the below category:
- Protein/Antibody Engineering
- Bioanalysis & Characterisation
- Next Generation Biotherapeutics
- Peptides Chemistry & Therapeutics
- Oligonucleotides Chemistry & Therapeutics
- Sustainable Chemistry & Manufacturing
- Student (PhD), PostDoc or early career scientist under 35 years of age. Proof must be provided via an active student ID card or a copy of status
- Applicants must be the first AND presenting author of the submitted paper and register for the meeting by 13th January 2025
- ONLY ONE YSA submission per person will be accepted. If authors submit multiple abstracts for consideration for the YSA, only one abstract will be taken into consideration for the YSA
Applicants must follow the procedure as follows:
- Register and submit an abstract by 13th January 2025 using the registration link to the left on this page
- Once registered you will be provided with the online abstract submission form
- Prepare the poster or platform and present it (The poster presenter should be at the poster during all breaks.)
- The 3 winners with the highest scores will be announced at the Networking Drinks on the second day of the event
- The winners’ 10-minute oral presentations will take place during the networking drinks on day 2
The platform or poster presentation will be evaluated by senior scientists (consisting of our speaking and steering group committee for the NextGen Biomed series) on the basis of originality of the approach and quality of the work (e.g. appropriate methodology, interpretation of results, conclusiveness). All participants will receive the scoring and comments after the annual meeting via email.
The 3 winners receiving the highest scores will be announced at the Networking Drinks on the Day 2 and will be given a trophy as well as £1,000 contribution towards travel costs. Oxford Global will also provide winners with PLUS Pass – 12 months access to our content platform providing access to on-demand presentations, exclusive reports and highlights.